Several combination strategies have shown promise:
1. ABVD Regimen: A combination of doxorubicin, bleomycin, vinblastine, and dacarbazine, used for treating Hodgkin lymphoma. 2. FOLFOX: A regimen combining folinic acid, fluorouracil, and oxaliplatin, commonly used for colorectal cancer. 3. Checkpoint Inhibitors and Chemotherapy: Combining immune checkpoint inhibitors like pembrolizumab with chemotherapy drugs has shown effectiveness in various cancers, including lung cancer.
